2026-10-29Neutral
-15.05%24 hours changeHaleon cut FY organic growth guidance to around 2.5% from 3-5%, below the 3.2% consensus, and shares fell 15.05%.
read the report →← every name covered
FTSE 100
HLN.L
Haleon
latest move
-15.05%
2026-10-29
1 session · 2026-10-29 · avg 15.05% · largest 15.05%
Haleon is a consumer healthcare group spun off from GSK in July 2022. It sells oral health brands such as Sensodyne and Parodontax, vitamins such as Centrum, and over-the-counter cold, flu and allergy products.